Document Preview Unavailable
Assessment of 25-Year Survival of Women With Estrogen Receptor–Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial
Dar, Huma; Johansson, Annelie; Nordenskjöld, Anna; Iftimi, Adina; Yau, Christina; et al. JAMA Network Open Vol. 4, Iss. 6, (2021): e2114904.You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library




